LG Chem Ltd.

LG Chem Ltd.

229,000.00
KRW
-9,000.00
(-3.78%)
-36,763.09EPS
19.77TMarket Cap
Nov 05Next Earn
LG Chem Ltd.
KRX:051910
(Korea Stock Exchange)

Recent

price

229,000.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
264,746.03
344,031.85
316,267.74
314,640.42
306,908.48
274,693.46
280,865.05
335,109.35
367,778.09
356,572.44
390,868.42
546,834.75
653,949.14
705,628.17
622,163.33
586,797.04
673,203.06
Revenue per Share
29,345
32,436.4
20,318
17,211
11,798
15,674
17,417
25,367
19,217
4,085
6,666
47,108
23,670
17,086
-8,826
-23,244
-20,855.7
Basic EPS, GAAP
11,769.99
270.55
-2,376.7
10,616.29
7,246.06
19,917.07
14,194.41
10,825.44
-28,770.1
-43,923.09
2,359.46
-5,041.18
-102,663.06
-71,218.38
-99,233.88
-71,833.09
-59,666.68
Free Cash Flow per Basic Share
3,806.89
4,834.45
4,298.28
4,192.81
4,075.97
4,206.23
4,710.5
5,029.4
6,444.95
6,308.21
2,310.03
11,164.31
13,992.81
14,101.38
4,692.44
2,894.4
- -
Dividend per Share
116,297.61
144,365.77
160,687.98
175,369.03
183,607.36
196,526.54
210,877.45
233,973.02
247,238.44
246,106.05
256,684.99
308,371.62
444,979.25
455,490.77
470,953.86
464,741.01
501,354.43
Book Value per Share
113,564.93
141,222.58
157,139.37
171,377.41
175,641.81
188,911.98
198,252.24
207,527.46
218,137.19
214,103.86
224,173.97
273,564.8
406,870.26
403,177.42
419,682.56
415,134.99
449,658.41
Tangible Book Value per Share
74
66
74
74
74
74
74
77
77
77
77
78
78
78
78
78
73
Basic Weighted Avg Shares
19,471,450
22,675,593
23,263,019
23,143,612
22,577,830
20,206,583
20,659,296
25,698,014
28,183,013
27,353,078
30,058,872
42,599,284
50,983,251
55,249,785
48,699,754
45,932,167
48,815,994
Sales/Revenue/Turnover
14.64
12.59
8.21
7.53
5.81
9.02
9.64
11.4
7.97
3.02
6.01
11.8
5.84
4.58
1.8
2.57
1.67
Operating Margin (%)
672,110
756,668
873,538
1,045,233
1,150,224
1,256,082
1,336,693
1,402,042
1,487,269
1,856,467
2,310,959
2,840,908
3,396,079
3,957,503
4,682,360
5,257,905
5,826,908
Depreciation Expense
2,158,256
2,137,926
1,494,487
1,265,968
867,924
1,152,987
1,281,124
1,945,280
1,472,608
313,365
512,634
3,669,787
1,845,363
1,337,812
-690,854
-1,819,449
-1,512,310
Net Income, GAAP
21.95
22.42
19.9
20.65
26.37
25.88
22.82
21.14
21.69
29.45
38.65
25.26
22.93
17.31
- -
- -
- -
Effective Tax Rate (%)
11.08
9.43
6.42
5.47
3.84
5.71
6.2
7.57
5.23
1.15
1.71
8.61
3.62
2.42
-1.42
-3.96
-3.1
Profit Margin (%)
2,014,285
2,532,308
3,114,926
3,433,740
3,337,772
3,856,624
3,780,083
4,560,892
4,814,978
2,928,195
3,695,481
5,351,724
13,214,806
10,468,457
6,729,910
6,389,751
9,911,249
Working Capital
480,510
689,081
1,195,126
803,634
727,830
507,928
678,000
1,593,625
3,708,001
7,058,171
8,637,302
11,288,654
12,160,152
14,850,332
19,755,038
22,073,820
28,686,069
LT Debt
7,843,835
9,707,679
10,765,355
11,725,662
12,265,852
13,103,522
14,050,967
16,338,577
17,322,128
17,383,789
18,790,440
23,209,988
37,481,127
40,938,185
47,995,463
47,105,545
48,870,923
Total Equity
24.23
19.24
11.61
9.64
6.4
8.61
9.25
12.5
8.24
2.39
4.01
11
4.94
3.58
- -
- -
- -
Return on Invested Capital (%)
24.62
19.46
11.88
9.23
6.28
7.75
8.2
10.72
7.29
1.63
1.7
10.58
3.77
1.99
- -
- -
- -
Return on Capital (%)
32.92
24.89
14.87
11.43
7.34
9.2
9.54
12.96
8.88
1.84
2.93
18.51
6.95
4.21
-2.11
-5.51
-4.53
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
11,738,137
13,116,591
11,603,156
LT Borrowings
21,182,908
21,630,921
25,411,336
LT Finance Leases
890,912
907,271
3,274,733
Preferred Equity and Hybrid Capital
38,444
38,444
38,444
Shares Outstanding
71
71
71
Market Capitalization
23,507,250
21,107,110
19,765,855

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
32,526,899
34,427,033
37,485,351
Cash, Cash Equivalents & STI
10,902,789
9,686,782
12,702,537
Accounts Receivable, Net
6,724,744
8,342,612
9,475,720
Inventories
8,177,310
9,350,967
11,156,732
Total Current Liabilities
26,137,148
28,565,161
27,574,102
Payables & Accruals
- -
- -
- -
ST Debt
11,738,137
13,116,591
11,603,156
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.76%
21.92%
-1.85%
Free Cash Flow
113.56%
320.6%
-27.61%
Net Income, GAAP
57.39%
110.08%
163.36%
Sales/Revenue/Turnover
9.55%
10.45%
-5.68%
Total Cash Common Dividend
29.72%
62.23%
-38.32%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
11,609,432
12,241,915
12,620,267
12,336,602
48,699,754
2025
12,578,868
11,908,472
11,196,170
11,197,134
45,932,167
2026
12,246,789
14,175,901
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,742
-4,048
6,954
-13,483.5
-8,826
2025
-1,374
-5,549
1,691.32
-17,846.52
-23,244
2026
-4,932.82
1,607.16
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4,692.44
2025
- -
- -
- -
- -
2,894.4
2026
- -
- -
- -
- -
- -
Business
LG Chem Ltd. is a leading South Korean chemical company specializing in petrochemicals, advanced materials, and life sciences. The company manufactures a wide range of petrochemical products, including basic raw materials such as ethylene and propylene, plastics like polyvinyl chloride (PVC), acrylonitrile butadiene styrene (ABS), styrene-acrylonitrile resin (SAN), synthetic rubber, and engineering plastics. It also produces advanced materials such as cathode and anode binders for batteries, display and optical films including LCD polarizers, and circuit board materials. In the life sciences sector, LG Chem develops pharmaceuticals focusing on oncology and specialty care, with a recent acquisition of the U.S. biopharmaceutical firm AVEO Oncology to expand its oncology drug portfolio. The company operates manufacturing facilities and subsidiaries across Asia, North America, and Europe, with headquarters in Seoul, South Korea, and was founded in 1947. Recent major changes include strategic investments to strengthen battery materials production, such as the establishment of cathode material joint ventures and new plant construction in Tennessee, USA. LG Chem expanded its separation business through acquisition and advanced its sustainability initiatives by completing Asia’s first supercritical pyrolysis plant and entering a bio-refinery joint venture with Eni to support decarbonization efforts. It also signed a significant supply contract for cathode materials with General Motors valued at 25 trillion KRW and plans to enhance its commercial excellence and cost competitiveness through portfolio rationalization and selective capital investment. Additionally, the company is divesting non-core commodity chemical production lines and is reducing its stake in LG Energy Solution, aiming to refine its business portfolio towards high-value battery and pharmaceutical products. LG Chem continues to focus on eco-friendly materials development and expanding downstream operations to improve profitability and market presence globally.